Artivion, Inc. (AORT)
19.10
-0.30
(-1.55%)
USD |
NYSE |
Nov 13, 16:00
19.10
0.00 (0.00%)
Pre-Market: 19:59
Artivion Total Liabilities (Quarterly) : 595.69M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 595.69M |
| June 30, 2026 | 626.35M |
| March 31, 2026 | 432.69M |
| December 31, 2025 | 436.56M |
| September 30, 2025 | 418.97M |
| June 30, 2025 | 418.48M |
| March 31, 2025 | 496.91M |
| December 31, 2024 | 512.90M |
| September 30, 2024 | 498.40M |
| June 30, 2024 | 494.48M |
| March 31, 2024 | 489.02M |
| December 31, 2023 | 510.62M |
| September 30, 2023 | 502.81M |
| June 30, 2023 | 495.35M |
| March 31, 2023 | 477.16M |
| December 31, 2022 | 478.47M |
| September 30, 2022 | 487.62M |
| June 30, 2022 | 483.36M |
| March 31, 2022 | 484.36M |
| December 31, 2021 | 492.32M |
| September 30, 2021 | 507.11M |
| June 30, 2021 | 508.66M |
| March 31, 2021 | 497.50M |
| December 31, 2020 | 460.69M |
| September 30, 2020 | 456.43M |
| Date | Value |
|---|---|
| June 30, 2020 | 396.70M |
| March 31, 2020 | 344.42M |
| December 31, 2019 | 319.96M |
| September 30, 2019 | 315.10M |
| June 30, 2019 | 314.97M |
| March 31, 2019 | 314.31M |
| December 31, 2018 | 296.02M |
| September 30, 2018 | 292.89M |
| June 30, 2018 | 298.96M |
| March 31, 2018 | 302.19M |
| December 31, 2017 | 312.64M |
| September 30, 2017 | 102.78M |
| June 30, 2017 | 103.16M |
| March 31, 2017 | 105.93M |
| December 31, 2016 | 107.16M |
| September 30, 2016 | 104.70M |
| June 30, 2016 | 104.93M |
| March 31, 2016 | 103.00M |
| December 31, 2015 | 25.93M |
| September 30, 2015 | 28.09M |
| June 30, 2015 | 26.53M |
| March 31, 2015 | 24.35M |
| December 31, 2014 | 27.47M |
| September 30, 2014 | 28.30M |
| June 30, 2014 | 27.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 56.62B |
| AngioDynamics, Inc. | 77.97M |
| Alphatec Holdings, Inc. | 775.44M |
| AtriCure, Inc. | 184.31M |
| Baxter International, Inc. | 12.94B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.042B |
| Shareholders Equity (Quarterly) | 446.40M |
| Debt to Equity Ratio | 0.9118 |
| Current Ratio | 3.719 |
| Net Debt Paydown Yield | -2.57% |